Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (469)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
22
2023
388
3.040
 Why?
Anus Neoplasms
10
2023
25
2.090
 Why?
Stroke
8
2024
509
1.900
 Why?
Acquired Immunodeficiency Syndrome
11
2022
54
1.570
 Why?
Prostatic Hyperplasia
10
2015
37
1.430
 Why?
Brain
10
2024
1323
1.390
 Why?
Parkinson Disease
2
2023
155
1.230
 Why?
Randomized Controlled Trials as Topic
8
2024
594
1.200
 Why?
Chlamydia Infections
8
2017
76
1.190
 Why?
Papillomavirus Infections
6
2022
172
1.140
 Why?
Mesenchymal Stem Cell Transplantation
2
2024
19
1.070
 Why?
Sarcoma, Kaposi
12
2022
76
1.030
 Why?
Chlamydia trachomatis
6
2017
29
1.000
 Why?
Lymphoma, AIDS-Related
10
2020
16
0.970
 Why?
Brain Ischemia
2
2023
161
0.890
 Why?
Plant Extracts
5
2013
193
0.880
 Why?
Humans
103
2025
52336
0.850
 Why?
Serenoa
5
2013
7
0.850
 Why?
Rural Population
4
2023
572
0.780
 Why?
Phytotherapy
3
2012
45
0.780
 Why?
Umbilical Cord
2
2020
36
0.770
 Why?
Lymphoma, Non-Hodgkin
6
2021
58
0.710
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1031
0.700
 Why?
Middle Aged
50
2021
13014
0.690
 Why?
Research Design
5
2022
354
0.670
 Why?
Neonatal Abstinence Syndrome
3
2024
27
0.640
 Why?
Fetal Blood
2
2019
79
0.640
 Why?
Adult
50
2022
14139
0.630
 Why?
Male
59
2024
26696
0.630
 Why?
Inflammation
3
2021
642
0.600
 Why?
Rats
9
2024
3202
0.580
 Why?
Patient Participation
1
2018
69
0.580
 Why?
Vaginosis, Bacterial
2
2015
8
0.540
 Why?
Decision Making
1
2018
282
0.510
 Why?
Mammography
1
2016
97
0.500
 Why?
Antineoplastic Agents
10
2023
1222
0.500
 Why?
Neoplasms
3
2023
1305
0.500
 Why?
Stem Cells
3
2025
182
0.490
 Why?
Female
47
2024
28105
0.480
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
46
0.470
 Why?
Aged
28
2020
10109
0.460
 Why?
Infarction, Middle Cerebral Artery
3
2024
40
0.460
 Why?
Population Density
1
2014
16
0.460
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.460
 Why?
AIDS-Related Opportunistic Infections
5
2016
38
0.450
 Why?
Stem Cell Transplantation
4
2025
185
0.450
 Why?
Carcinoma in Situ
3
2013
72
0.440
 Why?
Cytokines
5
2023
625
0.430
 Why?
Animals
14
2025
13523
0.420
 Why?
Uterine Cervicitis
1
2013
3
0.420
 Why?
Anti-Bacterial Agents
5
2020
801
0.420
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.410
 Why?
Urethritis
2
2012
5
0.410
 Why?
Finasteride
4
2015
4
0.390
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
106
0.390
 Why?
Research Subjects
1
2013
52
0.390
 Why?
Guideline Adherence
1
2013
137
0.390
 Why?
Breast Neoplasms
3
2017
1206
0.380
 Why?
Subarachnoid Hemorrhage
1
2012
60
0.380
 Why?
Rats, Sprague-Dawley
5
2024
1552
0.380
 Why?
Patient Dropouts
1
2012
51
0.370
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
170
0.370
 Why?
Urologic Diseases
1
2011
9
0.360
 Why?
Homosexuality, Male
4
2022
51
0.360
 Why?
HIV-1
6
2020
59
0.360
 Why?
Analgesics, Opioid
4
2024
590
0.350
 Why?
Lung Neoplasms
2
2013
636
0.340
 Why?
Disease Models, Animal
5
2024
1484
0.330
 Why?
Young Adult
17
2019
4319
0.330
 Why?
Papillomaviridae
3
2019
105
0.330
 Why?
United States
10
2023
5182
0.330
 Why?
Patient Selection
1
2011
259
0.320
 Why?
Quality of Life
6
2024
868
0.320
 Why?
Lymphedema
2
2022
48
0.310
 Why?
HIV Seropositivity
3
2021
28
0.310
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.310
 Why?
Intestinal Mucosa
2
2021
224
0.310
 Why?
Asthma
2
2024
316
0.310
 Why?
Polymorphism, Single Nucleotide
3
2017
506
0.290
 Why?
Gonorrhea
2
2020
9
0.290
 Why?
Azithromycin
4
2020
26
0.290
 Why?
Uterine Cervical Neoplasms
2
2022
299
0.280
 Why?
Anal Canal
4
2023
27
0.270
 Why?
Risk Factors
8
2022
3872
0.270
 Why?
Th1 Cells
2
2017
55
0.270
 Why?
Prospective Studies
12
2022
2428
0.270
 Why?
Vascular Endothelial Growth Factor A
4
2017
186
0.260
 Why?
Mycoplasma genitalium
2
2018
2
0.250
 Why?
Doxazosin
3
2015
3
0.250
 Why?
Mycoplasma Infections
2
2018
7
0.250
 Why?
Prevalence
7
2021
1007
0.250
 Why?
Treatment Outcome
16
2020
5407
0.240
 Why?
Cyclophosphamide
9
2021
171
0.240
 Why?
Doxycycline
3
2015
33
0.240
 Why?
Cancer Vaccines
1
2006
78
0.240
 Why?
Anti-Infective Agents
2
2020
106
0.240
 Why?
Vincristine
8
2021
88
0.230
 Why?
Adolescent
13
2022
6692
0.230
 Why?
Multicenter Studies as Topic
4
2024
104
0.230
 Why?
Circadian Rhythm
1
2025
91
0.230
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
606
0.220
 Why?
Air Filters
1
2024
1
0.220
 Why?
Double-Blind Method
4
2013
713
0.220
 Why?
CD4 Lymphocyte Count
7
2020
33
0.220
 Why?
Bronchiolitis
1
2024
28
0.220
 Why?
Air Pollution, Indoor
1
2024
27
0.220
 Why?
5-alpha Reductase Inhibitors
2
2015
3
0.220
 Why?
Hyperbaric Oxygenation
1
2023
15
0.210
 Why?
Substantia Nigra
1
2023
14
0.210
 Why?
Cell Differentiation
3
2025
674
0.210
 Why?
alpha-Synuclein
1
2023
9
0.210
 Why?
Neoplasm Staging
5
2022
770
0.210
 Why?
Doxorubicin
8
2021
239
0.210
 Why?
Transplantation Conditioning
2
2018
93
0.210
 Why?
Cisplatin
3
2022
285
0.210
 Why?
Tumor Necrosis Factor-alpha
2
2017
397
0.200
 Why?
Informatics
1
2023
8
0.200
 Why?
Prednisone
7
2021
102
0.200
 Why?
Herpesvirus 8, Human
5
2020
98
0.200
 Why?
Follow-Up Studies
8
2019
2268
0.200
 Why?
Astrocytes
1
2024
138
0.200
 Why?
Cross-Sectional Studies
3
2021
1676
0.200
 Why?
Brachytherapy
1
2022
48
0.200
 Why?
Neuroprotective Agents
2
2020
101
0.200
 Why?
Watchful Waiting
1
2022
28
0.190
 Why?
Oxidative Phosphorylation
1
2022
46
0.190
 Why?
Medical Records
1
2022
86
0.190
 Why?
Absorptiometry, Photon
1
2003
162
0.190
 Why?
Feasibility Studies
2
2021
402
0.190
 Why?
Substance Withdrawal Syndrome
1
2023
168
0.190
 Why?
Vitamin D Deficiency
1
2022
45
0.190
 Why?
Brain Injuries
1
2023
158
0.190
 Why?
Viral Load
6
2020
80
0.190
 Why?
Vaccines
1
2022
51
0.190
 Why?
Genome-Wide Association Study
3
2018
186
0.190
 Why?
Child
7
2024
7157
0.190
 Why?
Precancerous Conditions
1
2022
85
0.190
 Why?
Case-Control Studies
3
2014
1201
0.190
 Why?
Lymphocyte Activation
3
2017
172
0.180
 Why?
Mouth Diseases
1
2021
5
0.180
 Why?
Clinical Trials as Topic
5
2020
468
0.180
 Why?
Vaccination
3
2022
297
0.180
 Why?
Mass Screening
2
2015
357
0.180
 Why?
Thymus Gland
1
2021
42
0.180
 Why?
Pluripotent Stem Cells
1
2021
8
0.180
 Why?
Progestins
1
2020
11
0.180
 Why?
Primary Health Care
2
2022
375
0.180
 Why?
Physical Conditioning, Animal
1
2021
62
0.180
 Why?
T-Lymphocyte Subsets
2
2017
41
0.180
 Why?
Drug Therapy, Combination
5
2015
395
0.180
 Why?
Vagina
2
2018
46
0.170
 Why?
Papillomavirus Vaccines
2
2013
69
0.170
 Why?
Etoposide
5
2021
72
0.170
 Why?
Spleen
1
2021
173
0.170
 Why?
Anti-HIV Agents
3
2020
46
0.170
 Why?
Enzyme Inhibitors
2
2016
374
0.170
 Why?
Cross-Over Studies
1
2021
238
0.170
 Why?
Genes, myc
1
2020
39
0.170
 Why?
Gene Frequency
2
2017
99
0.170
 Why?
Overweight
1
2022
224
0.170
 Why?
Transplantation, Autologous
3
2018
488
0.170
 Why?
Aged, 80 and over
5
2013
3391
0.160
 Why?
Nervous System Diseases
1
2020
94
0.160
 Why?
Dihydroxyphenylalanine
1
2019
5
0.160
 Why?
Dopaminergic Neurons
1
2019
19
0.160
 Why?
Ablation Techniques
1
2019
19
0.160
 Why?
Infant, Newborn
5
2024
2826
0.150
 Why?
Genitalia, Male
1
2019
14
0.150
 Why?
Sodium, Dietary
1
2019
24
0.150
 Why?
Altruism
1
2018
13
0.150
 Why?
Central Nervous System Diseases
1
2019
27
0.150
 Why?
Mouth
1
2019
33
0.150
 Why?
Asymptomatic Infections
1
2018
5
0.150
 Why?
Mitochondria
2
2020
428
0.150
 Why?
Dopamine
1
2019
172
0.150
 Why?
Antiviral Agents
2
2013
177
0.150
 Why?
Sexually Transmitted Diseases
1
2018
36
0.150
 Why?
Encephalitis
1
2018
39
0.140
 Why?
Hyperthermia, Induced
1
2019
114
0.140
 Why?
Chlamydia
1
2017
8
0.140
 Why?
Energy Metabolism
1
2020
306
0.140
 Why?
Mucous Membrane
1
2017
31
0.140
 Why?
Regeneration
1
2018
79
0.140
 Why?
Blood Cells
1
2017
37
0.140
 Why?
Exosomes
1
2018
56
0.140
 Why?
Pilot Projects
3
2019
719
0.140
 Why?
Protein Kinase Inhibitors
2
2023
230
0.140
 Why?
Biopsy
2
2022
604
0.140
 Why?
Genetic Predisposition to Disease
2
2018
528
0.140
 Why?
DNA, Circular
1
2017
18
0.140
 Why?
Antibodies, Bacterial
1
2017
30
0.140
 Why?
Clostridium Infections
1
2018
55
0.140
 Why?
Clonal Evolution
1
2017
58
0.130
 Why?
Immunoglobulins
1
2017
76
0.130
 Why?
Immunoglobulin G
1
2017
195
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
2
2017
236
0.130
 Why?
Anus Diseases
1
2016
2
0.130
 Why?
Sentinel Lymph Node Biopsy
1
2017
118
0.130
 Why?
Mannitol
1
2016
15
0.130
 Why?
Lymph Node Excision
1
2017
133
0.130
 Why?
Telemedicine
1
2022
493
0.130
 Why?
Guidelines as Topic
1
2016
110
0.130
 Why?
Thiazoles
1
2016
55
0.130
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
7
0.130
 Why?
Diagnostic Self Evaluation
1
2015
14
0.120
 Why?
Blood-Brain Barrier
1
2016
49
0.120
 Why?
CD4-Positive T-Lymphocytes
1
2017
165
0.120
 Why?
Dose-Response Relationship, Drug
4
2013
1377
0.120
 Why?
Educational Status
1
2016
227
0.120
 Why?
Tinidazole
2
2012
2
0.120
 Why?
T-Lymphocytes
1
2017
340
0.120
 Why?
Time Factors
6
2023
2957
0.120
 Why?
Imidazoles
1
2016
124
0.120
 Why?
Burkitt Lymphoma
1
2015
27
0.120
 Why?
Drug Administration Schedule
5
2020
372
0.120
 Why?
Lymph Nodes
1
2017
252
0.120
 Why?
Menarche
1
2014
7
0.110
 Why?
Stomatitis
1
2014
16
0.110
 Why?
Data Collection
3
2023
289
0.110
 Why?
Chromosomes, Human, Pair 2
1
2014
25
0.110
 Why?
Obesity
3
2022
1162
0.110
 Why?
Immunophenotyping
2
2017
117
0.110
 Why?
Disease-Free Survival
5
2016
460
0.110
 Why?
Hypogonadism
1
2013
12
0.110
 Why?
Benzamides
1
2013
50
0.110
 Why?
Carcinoma, Squamous Cell
1
2016
332
0.110
 Why?
Incidence
4
2018
1059
0.110
 Why?
Health Surveys
1
2014
238
0.100
 Why?
Urban Population
1
2014
162
0.100
 Why?
SEER Program
1
2013
103
0.100
 Why?
Regenerative Medicine
2
2025
12
0.100
 Why?
Organophosphonates
1
2013
7
0.100
 Why?
Testosterone
1
2013
141
0.100
 Why?
Perineum
1
2013
26
0.100
 Why?
DNA, Viral
3
2020
138
0.100
 Why?
Placebos
1
2013
85
0.100
 Why?
Cytosine
1
2013
30
0.100
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.100
 Why?
Piperazines
1
2013
117
0.100
 Why?
Heart Failure
1
2019
571
0.100
 Why?
tau Proteins
1
2012
26
0.100
 Why?
Prostate
2
2015
117
0.100
 Why?
Trichomonas Infections
1
2012
2
0.100
 Why?
HIV
3
2023
25
0.100
 Why?
Trichomonas vaginalis
1
2012
3
0.100
 Why?
Transforming Growth Factor beta1
1
2012
62
0.100
 Why?
Pyrimidines
1
2013
199
0.100
 Why?
Sleep
2
2024
186
0.100
 Why?
Vulvar Neoplasms
1
2013
60
0.100
 Why?
Androgen Antagonists
1
2011
11
0.090
 Why?
Urination Disorders
1
2011
23
0.090
 Why?
Medicare
1
2013
274
0.090
 Why?
Sirolimus
1
2012
67
0.090
 Why?
Comorbidity
1
2013
624
0.090
 Why?
Antibiotics, Antineoplastic
1
2012
78
0.090
 Why?
CD8-Positive T-Lymphocytes
2
2017
132
0.090
 Why?
Kenya
2
2022
12
0.090
 Why?
Quinazolinones
1
2011
6
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.090
 Why?
Arkansas
1
2016
2028
0.090
 Why?
Social Class
1
2011
93
0.090
 Why?
Practice Guidelines as Topic
1
2013
487
0.090
 Why?
Multivariate Analysis
1
2012
590
0.080
 Why?
Chronic Disease
1
2012
583
0.080
 Why?
Prognosis
5
2017
2094
0.080
 Why?
Piperidines
1
2011
97
0.080
 Why?
Plant Bark
1
2009
4
0.080
 Why?
Valproic Acid
1
2009
35
0.080
 Why?
Multiple Myeloma
2
2014
3049
0.080
 Why?
Ki-67 Antigen
1
2009
58
0.080
 Why?
Socioeconomic Factors
1
2012
606
0.080
 Why?
Colorectal Neoplasms
1
2013
295
0.080
 Why?
Logistic Models
1
2012
920
0.080
 Why?
India
2
2021
62
0.080
 Why?
Tetracyclines
2
2006
9
0.080
 Why?
Fruit
1
2009
127
0.080
 Why?
Neoplasm Recurrence, Local
1
2012
643
0.070
 Why?
Antiretroviral Therapy, Highly Active
3
2015
32
0.070
 Why?
Survival Analysis
3
2017
671
0.070
 Why?
Adaptive Immunity
2
2017
33
0.070
 Why?
Glioblastoma
1
2009
97
0.070
 Why?
Chemoradiotherapy
2
2019
50
0.070
 Why?
Sexual Partners
2
2018
38
0.070
 Why?
Stress, Psychological
1
2009
273
0.070
 Why?
Disease Progression
4
2013
870
0.070
 Why?
Regression Analysis
2
2018
401
0.070
 Why?
Chaperonins
1
2006
3
0.060
 Why?
Chaperonin 60
1
2006
6
0.060
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.060
 Why?
Lymphocyte Count
1
2006
20
0.060
 Why?
Papillomavirus E7 Proteins
1
2006
32
0.060
 Why?
Sexual Behavior
2
2018
127
0.060
 Why?
Viral Vaccines
1
2006
16
0.060
 Why?
Immunohistochemistry
3
2017
985
0.060
 Why?
HIV Protease Inhibitors
1
2006
3
0.060
 Why?
Interferon-alpha
1
2006
52
0.060
 Why?
Nephrosis, Lipoid
1
2005
5
0.060
 Why?
Infant
2
2024
3684
0.060
 Why?
Arterioles
1
2005
32
0.060
 Why?
Brain Neoplasms
1
2009
290
0.060
 Why?
Body Mass Index
2
2022
689
0.060
 Why?
Recombinant Fusion Proteins
1
2006
179
0.060
 Why?
Severity of Illness Index
2
2023
1021
0.060
 Why?
Circadian Clocks
1
2025
3
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
87
0.060
 Why?
Administration, Oral
4
2013
451
0.060
 Why?
Administration, Intranasal
1
2024
31
0.060
 Why?
Anti-Retroviral Agents
2
2019
19
0.060
 Why?
Phenotype
2
2017
799
0.060
 Why?
Neutropenia
2
2020
115
0.060
 Why?
Genotype
2
2017
569
0.060
 Why?
Confidence Intervals
2
2015
158
0.060
 Why?
Dust
1
2024
23
0.050
 Why?
Carbon
1
2024
55
0.050
 Why?
Particulate Matter
1
2024
63
0.050
 Why?
Cytochrome P-450 CYP3A
1
2023
78
0.050
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
6
0.050
 Why?
Hip
1
2003
23
0.050
 Why?
Bacterial Proteins
1
2006
361
0.050
 Why?
Oligomycins
1
2022
8
0.050
 Why?
Rotenone
1
2022
15
0.050
 Why?
Galactose
1
2022
29
0.050
 Why?
Narcotics
1
2023
108
0.050
 Why?
Quality Control
1
2003
97
0.050
 Why?
Sample Size
1
2022
44
0.050
 Why?
Eating
1
2023
159
0.050
 Why?
Breast Feeding
1
2024
197
0.050
 Why?
Vitamins
1
2022
64
0.050
 Why?
Femur
1
2003
133
0.050
 Why?
Spine
1
2003
88
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
10
0.050
 Why?
Glycolysis
1
2022
73
0.050
 Why?
Tetracycline
1
2002
20
0.050
 Why?
Vitamin D
1
2022
89
0.050
 Why?
Radiotherapy Dosage
1
2022
255
0.050
 Why?
Sodium
1
2022
94
0.050
 Why?
Tretinoin
1
2002
54
0.050
 Why?
Leg
1
2022
120
0.050
 Why?
Fibroblast Growth Factor 2
2
2017
35
0.050
 Why?
Antibodies, Monoclonal
1
2005
481
0.040
 Why?
Museums
1
2021
2
0.040
 Why?
Alprostadil
1
2021
10
0.040
 Why?
Ischemia
1
2022
153
0.040
 Why?
Progesterone
1
2020
58
0.040
 Why?
Oxygen
1
2023
336
0.040
 Why?
Length of Stay
1
2024
659
0.040
 Why?
Kidney
1
2005
708
0.040
 Why?
Zimbabwe
1
2020
3
0.040
 Why?
Receptors, Progesterone
1
2020
66
0.040
 Why?
Malawi
1
2020
14
0.040
 Why?
Wharton Jelly
1
2020
2
0.040
 Why?
Uganda
1
2020
38
0.040
 Why?
Software
1
2003
279
0.040
 Why?
Spinal Cord Injuries
1
2020
55
0.040
 Why?
Cell Shape
1
2020
21
0.040
 Why?
Body Composition
1
2003
339
0.040
 Why?
Herpesvirus 4, Human
1
2020
44
0.040
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Glucose
1
2022
357
0.040
 Why?
Herpesviridae Infections
1
2020
57
0.040
 Why?
Ceftriaxone
1
2020
24
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
58
0.040
 Why?
B-Lymphocytes
1
2021
185
0.040
 Why?
Thrombocytopenia
1
2020
89
0.040
 Why?
Drug Resistance, Bacterial
1
2020
81
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Remission Induction
2
2012
218
0.040
 Why?
Interleukin-6
2
2016
278
0.040
 Why?
Kaplan-Meier Estimate
1
2020
484
0.040
 Why?
Microbial Sensitivity Tests
1
2020
286
0.040
 Why?
Radiation-Sensitizing Agents
1
2019
52
0.040
 Why?
Forelimb
1
2018
4
0.040
 Why?
Cell Survival
1
2020
602
0.040
 Why?
Green Fluorescent Proteins
1
2018
89
0.040
 Why?
Statistics, Nonparametric
2
2013
192
0.040
 Why?
Rats, Inbred F344
1
2018
195
0.040
 Why?
Models, Animal
1
2019
228
0.040
 Why?
Receptors, Chemokine
1
2017
13
0.040
 Why?
Cluster Analysis
1
2018
232
0.040
 Why?
Coinfection
1
2018
44
0.040
 Why?
Postural Balance
1
2018
59
0.040
 Why?
Neurodegenerative Diseases
1
2019
81
0.040
 Why?
Pandemics
1
2022
585
0.040
 Why?
Bone Marrow
1
2019
364
0.040
 Why?
Neurogenesis
1
2017
27
0.030
 Why?
Cell Separation
1
2017
74
0.030
 Why?
Muscle Strength
1
2018
131
0.030
 Why?
Cytological Techniques
1
2017
13
0.030
 Why?
Angiopoietin-2
1
2017
14
0.030
 Why?
Interleukin-2
1
2017
69
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Axilla
1
2017
92
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
47
0.030
 Why?
Staining and Labeling
1
2017
92
0.030
 Why?
Fluorouracil
1
2016
59
0.030
 Why?
Gene Rearrangement
1
2017
75
0.030
 Why?
Biopsy, Needle
1
2017
182
0.030
 Why?
Odds Ratio
1
2018
558
0.030
 Why?
Membrane Glycoproteins
1
2017
244
0.030
 Why?
Interferon-gamma
1
2017
179
0.030
 Why?
Mastectomy
1
2017
143
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
9
0.030
 Why?
Directly Observed Therapy
1
2015
7
0.030
 Why?
Urine
1
2015
25
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
17
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
Flow Cytometry
1
2017
404
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
RNA, Viral
2
2009
125
0.030
 Why?
Neoadjuvant Therapy
1
2017
125
0.030
 Why?
Treatment Failure
1
2015
122
0.030
 Why?
Prisons
1
2015
39
0.030
 Why?
Ifosfamide
1
2015
9
0.030
 Why?
Cytarabine
1
2015
42
0.030
 Why?
Magnetic Resonance Imaging
1
2022
1543
0.030
 Why?
Methotrexate
1
2015
77
0.030
 Why?
Induction Chemotherapy
1
2014
64
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
58
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
19
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
33
0.030
 Why?
Depression
1
2019
600
0.030
 Why?
Melphalan
1
2014
181
0.030
 Why?
Cohort Studies
1
2018
1532
0.030
 Why?
Statistics as Topic
1
2013
87
0.030
 Why?
Cancer Care Facilities
1
2013
19
0.030
 Why?
Time
1
2013
28
0.030
 Why?
Administration, Cutaneous
1
2013
53
0.030
 Why?
Infusions, Intravenous
1
2013
220
0.030
 Why?
Gene Expression Regulation
1
2017
1006
0.030
 Why?
Specialization
1
2013
49
0.030
 Why?
Demography
1
2013
92
0.020
 Why?
Molecular Targeted Therapy
1
2013
134
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
62
0.020
 Why?
Antitrichomonal Agents
1
2012
1
0.020
 Why?
Combined Modality Therapy
1
2014
636
0.020
 Why?
Risk Assessment
1
2017
1323
0.020
 Why?
Reference Values
1
2013
313
0.020
 Why?
Polyethylene Glycols
1
2012
89
0.020
 Why?
Antigens, Viral
1
2012
43
0.020
 Why?
Medical Oncology
1
2013
104
0.020
 Why?
Administration, Topical
1
2011
60
0.020
 Why?
Single-Blind Method
1
2011
116
0.020
 Why?
Neoplasm Proteins
1
2013
334
0.020
 Why?
Organ Size
1
2011
231
0.020
 Why?
Sex Factors
1
2013
727
0.020
 Why?
Retrospective Studies
1
2022
6578
0.020
 Why?
Antibodies, Viral
1
2010
110
0.020
 Why?
Survival Rate
1
2012
940
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
323
0.020
 Why?
Busulfan
1
2008
17
0.020
 Why?
Psychometrics
1
2009
230
0.020
 Why?
Mutation
1
2013
1351
0.020
 Why?
Mice
1
2017
5965
0.020
 Why?
Ultrasonography
1
2008
424
0.020
 Why?
Maximum Tolerated Dose
1
2006
39
0.020
 Why?
Injections, Subcutaneous
1
2006
50
0.020
 Why?
Hypertension, Renal
1
2005
21
0.020
 Why?
Cell Proliferation
1
2009
1029
0.010
 Why?
Fatigue
1
2006
125
0.010
 Why?
Recombinant Proteins
1
2006
491
0.010
 Why?
Receptors, Interleukin-6
1
2002
23
0.010
 Why?
Endothelial Growth Factors
1
2002
10
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
14
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Drug Tolerance
1
2002
60
0.010
 Why?
Safety
1
2002
79
0.010
 Why?
Child, Preschool
1
2005
4030
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (469) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department